To further assess the specificity of the observed enrichment in DDR pathways, we compared RNA-seq from CD19+ spleen cells isolated from Asxl1/Ezh2 dKO or TCL1 CLL mice with WT CD19+ spleen cells. The gene discussed is EZH2; the disease is B-cell chronic lymphocytic leukemia.